Wordt geladen...
Epigenetic modulators as therapeutic targets in prostate cancer
Prostate cancer is one of the most common non-cutaneous malignancies among men worldwide. Epigenetic aberrations, including changes in DNA methylation patterns and/or histone modifications, are key drivers of prostate carcinogenesis. These epigenetic defects might be due to deregulated function and/...
Bewaard in:
Gepubliceerd in: | Clin Epigenetics |
---|---|
Hoofdauteurs: | , , , , , |
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
BioMed Central
2016
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5025578/ https://ncbi.nlm.nih.gov/pubmed/27651838 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13148-016-0264-8 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|